Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03350815
Brief Title: Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis (ASLeap)

First Submitted : October 31, 2017
First Submitted that Met QC Criteria : November 20, 2017
First Posted : November 22, 2017

Last Update Submitted that Met QC Criteria : September 29, 2020
Last Update Posted : October 1, 2020